Eluminex Biosciences
PrivateLast Round
Series B
Feb 27, 2023
Total Funding Raised
$90M
Company Overview
Eluminex Biosciences is a biotechnology company that develops and commercializes innovative ophthalmic therapeutic solutions, including protein therapeutics and recombinant human collagen-based products, to treat vision-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eluminex Biosciences Comparables
Compare Eluminex Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VivaVision Biotech | 84% | |
| Arctic Vision | 79% | |
| ActualEyes, Inc. | 79% | |
Eluminex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 27, 2023 | ||||
| Series A | Nov 27, 2020 |
Eluminex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Bencao Capital | Series B |
| Cenova Capital | Series B |
| GL Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2023
$40M round led by Cenova Capital
- Nov 27, 2020
$50M round led by GL Ventures and Lilly Asia Ventures.
Eluminex Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eluminex Biosciences's valuation, stock price, and market status.